Elasty G™ Hyaluronic Acid Dermal Filler
HA 24 mg/ml with 0.3% Lidocaine
Elasty G™ is a premium dermal filler containing highly purified hyaluronic acid with integrated anesthetic. Utilizing PNET (Preserved Natural Entanglement Technology), it demonstrates 98.7% patient satisfaction in clinical trials with 8-12 month duration. The formulation shows 30% higher cohesion than conventional fillers and reduces pain scores by 67% versus standard treatments.
- High Safety Profile: 0.02% adverse reaction rate with triple purification process
- Enhanced Comfort: Integrated anesthetic reduces pain by 67% versus standard fillers
- Structural Superiority: PNET technology increases cross-linking density by 40%
- Long-Lasting Results: Clinically proven 8-12 month duration in facial treatments
Hyaluronic Acid 24 mg/ml, Lidocaine HCl 0.3%
Sterile syringe with needle
2-25°C protected from light
Dongbang Medical Co., Ltd. (GMP Certified)
Adverse Effects: Temporary swelling, redness, or bruising may occur
Professional Note: Results vary based on skin type, injection technique, and metabolic factors
Warning: Must be administered by licensed practitioners only
Precaution: Consultation with a board-certified specialist is mandatory prior to treatment
• Elasty G requires prescription and professional administration by qualified practitioners
• Always follow aseptic techniques during administration
• Monitor for hypersensitivity reactions during and after treatment
• Store according to manufacturer’s guidelines
• Manufacturer not liable for improper storage or administration errors
We are an authorized wholesale distributor of medical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product specifications may vary and should be confirmed with actual product packaging. Images shown are for illustrative purposes only.
Reviews
There are no reviews yet.